Use this url to cite publication: https://hdl.handle.net/20.500.12512/90313
Once Daily Dosing of 9mg Budesonide (Budenofalk®) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study
Type of publication
Tezės Web of Science duomenų bazėje / Theses in Web of Science database (T1a1)
Author(s)
| Author | Affiliation |
|---|---|
Dignass, Axel | |
Title
Once Daily Dosing of 9mg Budesonide (Budenofalk®) Is Therapeutic Equivalent to a Three-Times Daily Dosing of 3mg Budesonide for the Treatment of Active Crohn's Disease: A Randomized, Double-Blind, Double-Dummy, Multicenter Phase III Study
Axel U. Dignass, Simeon Stoynov, Andrey E. Dorofeyev, Galina A. Grigorieva, Eva Tomsova, István Altorjay, Daniel Tuculanu, Ivan Bunganic, Juris Pokrotnieks, Limas Kupcinskas, Roland Greinwald, Ralph Mueller
Publisher (trusted)
W.B. Saunders
Is Referenced by
Date Issued
| Date |
|---|
2013 |
Extent
p. S-233, no. Sa1217.
Is part of
Gastroenterology : 2013 DDW Abstract Supplement to Gastroenterology / AGA (American Gastroenterological Association) Institute. Philadelphia, PA : W.B. Saunders ; Elsevier, 2013, vol. 144, iss. 5, suppl. 1, May.
Version
Originalus / Original
Series/Report no.
Abstract.
Abstract.
Field of Science
Type of document
type::text::conference output::conference proceedings::conference paper
ISSN (of the container)
0016-5085
Other Identifier(s)
(LSMU ALMA)990000813550107106
Coverage Spatial
Jungtinės Amerikos Valstijos / United States of America (US)
Language
Anglų / English (en)